News & Articles

Standing out in Singapore’s crowded health supplement industry requires more than quality products. Voluntary HSA notification demonstrates safety, compliance, and transparency, all of which are values that retailers and consumers demand. This article explores how early notification builds authority, eases retail entry, and safeguards your business against future regulation, helping your brand thrive in the fast-growing wellness sector.

Singapore’s TCM market is growing, but strict HSA requirements make compliance essential. In this guide, we break down everything Chinese companies need to know about classification, licensing, labelling, and post-market obligations. Learn how to avoid missteps and ensure your Chinese proprietary medicine is safe, compliant, and ready for successful entry into the highly regulated healthcare landscape in Singapore

Registering pharmaceutical products in Singapore requires more than ticking boxes. In this article, we provide valuable tips and practical insights for building a strategic pharmaceutical registration roadmap, covering pathway selection, pre-submission planning, and post-market responsibilities. Learn how to reduce risks, streamline approvals, and maintain compliance with structured steps designed to support sustainable long-term market access.

In Singapore, regulatory submissions cannot move forward without a local authorised representative. A regulatory consultant fills this role, serving as a liaison with HSA, preventing costly errors, and managing ongoing compliance. The result? Stronger approval success, faster timelines, and peace of mind for international manufacturers entering the Singapore healthcare and pharmaceutical market. Keep reading to learn more.

Singapore is moving toward eCTD submission as the standard for new drug, generic, and biologics applications. While the system promises efficiency, it also demands precision. In this article, discover how to avoid common errors, strengthen lifecycle management, and align with HSA and ICH standards to ensure smoother approvals, long-term compliance, and future regulatory readiness in Singapore.

The ASEAN pharmaceutical market is rapidly expanding, but fragmented regulations can delay product launches. In this comprehensive guide, we explore how harmonisation with the ACTD, centralised dossier management, and expert guidance help companies streamline submissions, reduce costs, and navigate country-specific requirements with ease. Unlock faster approvals, stronger compliance, and sustainable market access across the region’s dynamic healthcare landscape.